复合益生菌制剂缓解cuprizone诱导的小鼠神经脱髓鞘
作者:
基金项目:

山西省省筹资金资助回国留学人员科研项目(2020-079);山西省应用基础研究面上青年基金(201901D211321)


Compound probiotics alleviate cuprizone-induced demyelination in mice
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [27]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    【目的】探索复合益生菌制剂对双环己酮草酰二腙(cuprizone,CPZ)诱导的小鼠脑内神经脱髓鞘的作用。【方法】将27只小鼠随机分为正常组(NC)、模型组(CPZ)和益生菌处理组(probiotics)。NC组小鼠正常饲喂,CPZ组和probiotics组小鼠饲喂含0.2% CPZ的饲料且每天分别灌饲0.2 mL生理盐水及同体积(75亿菌落形成单位活菌)的复合益生菌制剂,6周后处死小鼠。通过快蓝染色(LFB)观察小鼠脑内神经髓鞘的完整性;苏木素-伊红染色(HE)、阿利新蓝染色及免疫荧光染色分别评估回肠及结肠组织病理学改变、黏蛋白的表达及紧密连接蛋白ZO-1、occludin的表达;ELISA检测脑组织匀浆脂多糖LPS水平;Western blotting检测脑组织TLR4/NF-κB信号通路的蛋白表达。【结果】与CPZ组相比,复合益生菌制剂干预后,发生在CPZ组小鼠大脑胼胝体内的神经脱髓鞘明显减少;回肠绒毛排列整齐致密,结肠腺体增多,炎细胞浸润减少,黏蛋白及紧密连接蛋白表达均增加;脑组织LPS水平显著降低,TLR4、NF-κB及P-IκB/IκB蛋白表达量下降。【结论】复合益生菌制剂可能通过降低肠壁通透性缓解CPZ诱导的小鼠中枢神经系统脱髓鞘。

    Abstract:

    [Objective] To explore the effects of compound probiotics on demyelination of the mice induced by bis-cyclohexanone-oxalyldihydrazone (cuprizone, CPZ).[Methods] Twenty-seven mice were randomly assigned into normal (NC) group, model (CPZ) group, and probiotics group. The mice in the NC group were fed with normal diet, and those in the CPZ group and probiotics group with the diet containing 0.2% CPZ. The mice in the CPZ group and probiotics group were fed with 0.2 mL normal saline and 0.2 mL compound probiotics (7.5 billion colony-forming units) per day, respectively. All the mice were sacrificed after 6 weeks. Luxol fast blue (LFB) staining was employed to observe myelin sheath in the cerebrum. The histopathological change and the expression of mucin and tight junction proteins (ZO-1 and occludin) in ileum and colon were detected by hematoxylin-eosin (HE) staining, Alcian blue staining, and immunofluorescence staining, respectively. The content of lipopolysaccharide (LPS) in brain homogenate was detected by ELISA. The expression of proteins involved in the Toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway was detected by Western blotting.[Results] Compared with the CPZ group, compound probiotics significantly alleviated the demyelination in corpus callosum. In addition, the mice in the probiotics group showed neat and dense ileum villi, increased colon glands, decreased infiltration of inflammatory cells, and up-regulated expression of mucin and tight junction proteins, declined LPS level, and down-regulated expression of TLR4, NF-κB, and P-IκB/IκB in the brain.[Conclusion] Compound probiotics may alleviate CPZ-induced demyelination in mice by reducing intestinal wall permeability.

    参考文献
    [1] Niu JQ, Tsai HH, Hoi KK, Huang NX, Yu GD, Kim K, Baranzini SE, Xiao L, Chan JR, Fancy SPJ. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nature Neuroscience, 2019, 22(5):709-718.
    [2] Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O. Five decades of cuprizone, an updated model to replicate demyelinating diseases. Current Neuropharmacology, 2019, 17(2):129-141.
    [3] Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, Patel B, Mazzola MA, Liu SR, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, Smith K, Topçuolu BD, Holden J, Kivisäkk P, Chitnis T, De Jager PL, Quintana FJ, Gerber GK, Bry L, Weiner HL. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications, 2016, 7:12015.
    [4] Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-modulated metabolites at the interface of host immunity. Journal of Immunology, 2017, 198(2):572-580.
    [5] Alkasir R, Li J, Li XD, Jin M, Zhu BL. Human gut microbiota:the links with dementia development. Protein & Cell, 2017, 8(2):90-102.
    [6] Paone P, Cani PD. Mucus barrier, mucins and gut microbiota:the expected slimy partners? Gut, 2020, 69(12):2232-2243.
    [7] Hansson GC. Mucus and mucins in diseases of the intestinal and respiratory tracts. Journal of Internal Medicine, 2019, 285(5):479-490.
    [8] Gharehkhani Digehsara S, Name N, Esfandiari B, Karim E, Taheri S, Tajabadi-Ebrahimi M, Arasteh J. Effects of Lactobacillus casei strain T2(IBRC-M10783) on the modulation of Th17/treg and evaluation of miR-155, miR-25, and IDO-1 expression in a cuprizone-induced C57BL/6 mouse model of demyelination. Inflammation, 2021, 44(1):334-343.
    [9] Calvo-Barreiro L, Eixarch H, Ponce-Alonso M, Castillo M, Lebrón-Galán R, Mestre L, Guaza C, Clemente D, Del Campo R, Montalban X, Espejo C. A commercial probiotic induces tolerogenic and reduces pathogenic responses in experimental autoimmune encephalomyelitis. Cells, 2020, 9(4):906.
    [10] Berghoff SA, Gerndt N, Winchenbach J, Stumpf SK, Hosang L, Odoardi F, Ruhwedel T, Böhler C, Barrette B, Stassart R, Liebetanz D, Dibaj P, Möbius W, Edgar JM, Saher G. Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nature Communications, 2017, 8:14241.
    [11] Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S. The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine, 2014, 6(263):263ra158.
    [12] Ho J, Chan H, Liang YH, Liu XD, Zhang L, Li Q, Zhang YC, Zeng JD, Ugwu FN, Ho IHT, Hu W, Yau JCW, Wong SH, Wong WT, Ling L, Cho CH, Gallo RL, Gin T, Tse G, Yu J, Chan MTV, Leung CCH, Wu WKK. Cathelicidin preserves intestinal barrier function in polymicrobial sepsis. Critical Care:London, England, 2020, 24(1):47.
    [13] Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, Group MS, Platform EMS. New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis:Houndmills, Basingstoke, England, 2017, 23(8):1123-1136.
    [14] Feng X, Bao RY, Li L, Deisenhammer F, Arnason BGW, Reder AT. Interferon-β corrects massive gene dysregulation in multiple sclerosis:short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine, 2019, 49:269-283.
    [15] Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology, 2013, 13(11):790-801.
    [16] Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. Gut microbiota are related to Parkinson's disease and clinical phenotype. Movement Disorders, 2015, 30(3):350-358.
    [17] Hosseinifard ES, Morshedi M, Bavafa-Valenlia K, Saghafi-Asl M. The novel insight into anti-inflammatory and anxiolytic effects of psychobiotics in diabetic rats:possible link between gut microbiota and brain regions. European Journal of Nutrition, 2019, 58(8):3361-3375.
    [18] Camara-Lemarroy CR, Metz LM, Yong VW. Focus on the gut-brain axis:multiple sclerosis, the intestinal barrier and the microbiome. World Journal of Gastroenterology, 2018, 24(37):4217-4223.
    [19] Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Daneshvar Kakhaki R, Akbari E, Tajabadi-Ebrahimi M, Jafari P, Asemi Z. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis:a randomized, double-blind, placebo- controlled trial. Clinical Nutrition, 2017, 36(5):1245-1249.
    [20] Al-Ghezi ZZ, Busbee PB, Alghetaa H, Nagarkatti PS, Nagarkatti M. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain, Behavior, and Immunity, 2019, 82:25-35.
    [21] Jiao FZ, Wang Y, Zhang HY, Zhang WB, Wang LW, Gong ZJ. Histone deacetylase 2 inhibitor CAY10683 alleviates lipopolysaccharide induced neuroinflammation through attenuating TLR4/NF-κB signaling pathway. Neurochemical Research, 2018, 43(6):1161-1170.
    [22] Escribano BM, Medina-Fernández FJ, Aguilar-Luque M, Agüera E, Feijoo M, Garcia-Maceira FI, Lillo R, Vieyra-Reyes P, Giraldo AI, Luque E, Drucker-Colín R, Túnez I. Lipopolysaccharide binding protein and oxidative stress in a multiple sclerosis model. Neurotherapeutics, 2017, 14(1):199-211.
    [23] Yang XQ, Yu DK, Xue L, Li H, Du JR. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharmaceutica Sinica B, 2020, 10(3):475-487.
    [24] Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. Journal of Neuroimmunology, 2019, 328:98-104.
    [25] Xu YH, Gao CL, Guo HL, Zhang WQ, Huang W, Tang SS, Gan WJ, Xu Y, Zhou H, Zhu Q. Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice. The Journal of Endocrinology, 2018, 238(3):231-244.
    [26] Uchimura Y, Fuhrer T, Li H, Lawson MA, Zimmermann M, Yilmaz B, Zindel J, Ronchi F, Sorribas M, Hapfelmeier S, Ganal-Vonarburg SC, Gomez De Agüero M, McCoy KD, Sauer U, MacPherson AJ. Antibodies set boundaries limiting microbial metabolite penetration and the resultant mammalian host response. Immunity, 2018, 49(3):545-559.e5.
    [27] Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell, 2016, 165(7):1762-1775.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

杨昊,李琳,刘青青,康行,杨晓丹,刘海霞,樊卫平. 复合益生菌制剂缓解cuprizone诱导的小鼠神经脱髓鞘[J]. 微生物学报, 2022, 62(3): 774-784

复制
相关视频

分享
文章指标
  • 点击次数:588
  • 下载次数: 13777
  • HTML阅读次数: 2150
  • 引用次数: 0
历史
  • 收稿日期:2021-07-07
  • 最后修改日期:2021-09-14
  • 在线发布日期: 2022-03-07
文章二维码